Guru Ownership Trend
Guru Analysis for Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $150.02 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.17 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies reduced exposure by 36.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Relay Therapeutics, Inc. (RLAY)
Major holders include Steven Cohen ($77.12 M), Cliff Asness ($6.79 M), Renaissance Technologies ($5.48 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 16.8 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.17 M, with 0 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited RLAY. The total reported sell value was $3.17 M.
No tracked managers opened new positions or increased their holdings in RLAY during the most recent reporting period.